Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Université Laval

$122,400.00

Maternal serum Brain-Derived Neurotrophic Factor (BDNF): Study of a promising biomarker of maternal psychological stress during pregnancy

EF 2021-22

Résumé
Maternal stress in pregnancy has many potential negative consequences for the mother and her child. Among the consequences, maternal psychological stress affects birthweight, the occurrence of preeclampsia, reduces gestational duration and augments the risk of postpartum depression. Birthweight, in itself, is a major predictor of the newborn short and long-term health. We have previously shown that maternal prenatal stress is associated with birthweight in a sex-specific manner, being decreased in in girls and increased in boys. Among diverse biological alterations associated with maternal stress, neutrophins, in particular brain-derived neurotrophic factor (BDNF), were observed to be in lower concentration in the blood of stressed pregnant women. It is hypothesized that altered intrauterine levels of BDNF may lead to abnormal foetal growth and brain neurodevelopment, which have implications for cognitive parameters such as memory, spatial learning, mood and anxiety. BDNF is thought to regulate the development of the placenta and of the foetus brain. Studies have confirmed abnormally low blood BDNF levels in depressed pregnant women. A better understanding of the pathophysiological consequences of maternal stress through the measurement in maternal blood of recognized factors considered to play a role may lead to the identification of biological markers of the intensity of stress, offering the possibility to better therapeutic interventions. BDNF may be such a candidate marker worth investigating. Longitudinal studies on BDNF changes across gestation are limited. Taking advantage of our already constituted database and biobank of almost 8000 pregnant participants and their neonates, we will study the levels of BDNF in maternal blood and in cord serum. We will relate the results to the degree of maternal stress and birthweight. This will help to better understand the effect of maternal stress and to improve personalized therapeutic approaches.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
451440
Name
Giguere Yves
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Clinical Investigation - A: Reproduction, Maternal, Child and Youth Health 2
Projecttitle
Maternal serum Brain-Derived Neurotrophic Factor (BDNF): Study of a promising biomarker of maternal psychological stress during pregnancy
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$122,400
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Bdnf; Birthweight; Maternal Prenatal Stress; Prematurity; Stress Biomarker
Abstract
Maternal stress in pregnancy has many potential negative consequences for the mother and her child. Among the consequences, maternal psychological stress affects birthweight, the occurrence of preeclampsia, reduces gestational duration and augments the risk of postpartum depression. Birthweight, in itself, is a major predictor of the newborn short and long-term health. We have previously shown that maternal prenatal stress is associated with birthweight in a sex-specific manner, being decreased in in girls and increased in boys. Among diverse biological alterations associated with maternal stress, neutrophins, in particular brain-derived neurotrophic factor (BDNF), were observed to be in lower concentration in the blood of stressed pregnant women. It is hypothesized that altered intrauterine levels of BDNF may lead to abnormal foetal growth and brain neurodevelopment, which have implications for cognitive parameters such as memory, spatial learning, mood and anxiety. BDNF is thought to regulate the development of the placenta and of the foetus brain. Studies have confirmed abnormally low blood BDNF levels in depressed pregnant women. A better understanding of the pathophysiological consequences of maternal stress through the measurement in maternal blood of recognized factors considered to play a role may lead to the identification of biological markers of the intensity of stress, offering the possibility to better therapeutic interventions. BDNF may be such a candidate marker worth investigating. Longitudinal studies on BDNF changes across gestation are limited. Taking advantage of our already constituted database and biobank of almost 8000 pregnant participants and their neonates, we will study the levels of BDNF in maternal blood and in cord serum. We will relate the results to the degree of maternal stress and birthweight. This will help to better understand the effect of maternal stress and to improve personalized therapeutic approaches.
Competitiondate
202109
Approvedterm2
1 yr 6 mths
Pinamesdelim
Giguere, Yves; Forest, Jean-Claude
Approvedterm
1 an 6 mois
Cihrcontribution2
~ $122,400~ $0~